These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19058317)

  • 1. Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization.
    Zalinski S; Scatton O; Randone B; Vignaux O; Dousset B
    World J Gastroenterol; 2008 Nov; 14(44):6869-72. PubMed ID: 19058317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.
    Park GC; Lee SG; Yoon YI; Sung KB; Ko GY; Gwon DI; Jung DH; Jung YK
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):244-251. PubMed ID: 32414576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrally located small unifocal hepatocellular carcinoma between minor conservative liver resection and major hepatectomy. Case reports.
    De Raffele E; Mirarchi M; Caserta CA; Cuicchi D; Pendino GM; Lecce F; Cariani S; Cola B
    Ann Ital Chir; 2018; 89():128-137. PubMed ID: 29848810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous transcatheter arterial chemoembolization and portal vein embolization for patients with large hepatocellular carcinoma before major hepatectomy.
    Zhang CW; Dou CW; Zhang XL; Liu XQ; Huang DS; Hu ZM; Liu J
    World J Gastroenterol; 2020 Aug; 26(30):4489-4500. PubMed ID: 32874060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden.
    Ronot M; Cauchy F; Gregoli B; Breguet R; Allaham W; Paradis V; Soubrane O; Vilgrain V
    HPB (Oxford); 2016 Aug; 18(8):684-90. PubMed ID: 27485063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature.
    Piardi T; Memeo R; Renard Y; Ammendola M; Bruno O; Habersetzer F; Baumert T; Pessaux P; Sommacale D
    Minerva Chir; 2016 Jun; 71(3):192-200. PubMed ID: 26883849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma.
    Ogata S; Belghiti J; Farges O; Varma D; Sibert A; Vilgrain V
    Br J Surg; 2006 Sep; 93(9):1091-8. PubMed ID: 16779884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma.
    Yoo H; Kim JH; Ko GY; Kim KW; Gwon DI; Lee SG; Hwang S
    Ann Surg Oncol; 2011 May; 18(5):1251-7. PubMed ID: 21069467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma?
    Choi GH; Kim DH; Kang CM; Kim KS; Choi JS; Lee WJ; Kim BR
    World J Surg; 2007 Dec; 31(12):2370-7. PubMed ID: 17912587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC.
    Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA; Wang LF
    Asian Pac J Cancer Prev; 2014; 15(2):703-6. PubMed ID: 24568482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of portal vein embolization on treatment plan prior to major hepatectomy for hepatocellular carcinoma.
    Loveday BPT; Jaberi A; Moulton CA; Wei AC; Gallinger S; Beecroft R; Fischer S; Ghanekar A; McGilvray I; Sapisochin G; Greig PD; Tan K; Cleary SP
    HPB (Oxford); 2019 Aug; 21(8):1072-1078. PubMed ID: 30797726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
    Seo DD; Lee HC; Jang MK; Min HJ; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ; Ko GY; Lee YJ; Lee SG
    Ann Surg Oncol; 2007 Dec; 14(12):3501-9. PubMed ID: 17899289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Preoperative Portal Vein Embolization Outcomes in Patients with Hepatocellular Carcinoma: A Single-Center Experience.
    Marti J; Giacca M; Alshebeeb K; Bahl S; Hua C; Horn JC; BouAyache J; Patel R; Facciuto M; Schwartz M; Florman S; Kim E; Gunasekaran G
    J Vasc Interv Radiol; 2018 Jul; 29(7):920-926. PubMed ID: 29735260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma?
    Wakabayashi H; Ishimura K; Okano K; Izuishi K; Karasawa Y; Goda F; Maeba T; Maeta H
    Cancer; 2001 Nov; 92(9):2384-90. PubMed ID: 11745294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of segment 4 inferior by distal middle hepatic vein reconstruction combined with extended right hepatectomy after portal vein embolization in a patient with a huge initially unresectable HCC.
    Nakano H; Kikuchi K; Seta S; Katayama M; Yamamura T; Otsubo T
    Hepatogastroenterology; 2007; 54(77):1563-6. PubMed ID: 17708300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review.
    Glantzounis GK; Tokidis E; Basourakos SP; Ntzani EE; Lianos GD; Pentheroudakis G
    Eur J Surg Oncol; 2017 Jan; 43(1):32-41. PubMed ID: 27283892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of liver cirrhosis on percutaneous selective portal vein embolization for primary liver cancer].
    Sun JH; Zhang YL; Nie CH; Li J; Zhou TY; Zhou GH; Chen LM; He JD; Wu J; Shen Y; Zhang M; Wang WL; Zheng SS
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3831-4. PubMed ID: 24548443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.
    Majno PE; Adam R; Bismuth H; Castaing D; Ariche A; Krissat J; Perrin H; Azoulay D
    Ann Surg; 1997 Dec; 226(6):688-701; discussion 701-3. PubMed ID: 9409568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.